Clinical trial
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Trial of the Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
NCT01332253 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Trial of the Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
- Lead sponsor
- Cumberland Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- August 31, 2012
- Enrollment
- 161 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
tonsillectomy